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ABSTRACT
Chronic hepatitis C virus infection (HCV) can present with cryoglobulinemic vasculitis, which is primarily associated with type II/III cryoglobulins. Type I cryoglobulins are usually seen in lymphoproliferative disease, and large
vessel involvement with this type of vasculitis is rare. A 70-year-old man with chronic HCV presented with abdominal pain, leukocytosis, and rash. Computed tomography angiography showed thickening of the abdominal
aorta consistent with large-vessel vasculitis. He was found to have type I cryoglobulinemia and was treated with
corticosteroids and ledipasvir/sofosbuvir with rapid resolution of his aortitis. This case emphasizes the need to
recognize HCV as a potential etiology of large-vessel vasculitis.

INTRODUCTION
Chronic hepatitis C virus (HCV) infection can present with many extrahepatic manifestations, the most common of
which is cryoglobulinemia. Cryoglobulinemic vasculitis is characterized by the cold precipitation of serum cryoglobulins on endothelial surfaces, which elicits vascular inﬂammation through mechanisms that are not completely
understood. HCV is primarily associated with type II and type III cryoglobulins, which are mixtures of monoclonal
immunoglobulins IgM and polyclonal IgG and polyclonal IgM and IgG, respectively.1,2 In rare instances, type I cryoglobulins (monoclonal IgG or IgM, less commonly IgA) have also been seen with HCV, although type I cryoglobulinemia is classically described in lymphoproliferative disorders.3 HCV-associated cryoglobulinemic vasculitis
primarily affects small and medium-sized vessels of the skin, kidneys, and peripheral nerves.1 Involvement of large
vessels, such as the aorta, is unusual and rarely described in the literature.

CASE REPORT
A 70-year-old white man with a history of chronic, non-cirrhotic HCV (genotype 1a, treatment naïve) presented
with a 1-week history of right lower quadrant abdominal pain and a new, erythematous rash on his trunk and bilateral lower extremities. Laboratory studies included a leukocytosis of 14 K/mL, with normal renal function, liver function, and coagulation tests. Computed tomography angiography showed diffuse wall thickening of the distal
abdominal aorta and common iliac vessels without evidence of an aortic aneurysm or aortic dissection (Figure 1).
These ﬁndings were suspicious for focal, large-vessel vasculitis, and the patient was admitted.
Additional workup revealed an elevated erythrocyte sedimentation rate of 34 mm/hr and C-reactive protein 8.7
mg/dL. Human immunodeﬁciency virus, rapid plasma reagin, and treponemal antibody testing were negative. The
patient had a positive antinuclear antibody test (titer >1:1,280, nucleolar pattern), but p- and c-anti-neutrophil cytoplasmic antibody, IgG4 level, double-stranded DNA antibodies, anti-Smith antibodies, anti-ribonucleoprotein antibodies, and complement levels (C3/C4) were negative. HCV viral load was elevated at 183,424 IU/mL, and serum
ACG Case Rep J 2017;4:e114. doi:10.14309/crj.2017.114. Published online: October 25, 2017.
Correspondence: Adrienne Lenhart, Department of Internal Medicine, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202 (alenhar2@hfhs.org).
Copyright: © 2017 Lenhart et al. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.

ACG Case Reports Journal / Volume 4

acgcasereports.gi.org

1

Lenhart et al

HCV Aortitis and Type I Cryoglobulinemia

Figure 3. Magnetic resonance angiography of the abdomen showing resolution of aortitis in the distal aorta and proximal iliac vessels.

Figure 1. Computed tomography angiography of the abdomen showing
diffuse thickening of the walls of the abdominal aorta and common iliac
vessels.

was positive for type I cryoglobulins composed of IgG l
monoclonal proteins. Serum protein electrophoresis was
unremarkable.
Punch biopsy of the patient’s rash showed papillary dermal
edema and a mild superﬁcial perivascular inﬂammatory inﬁltrate, consistent with a non-speciﬁc, superﬁcial perivascular
dermatitis (Figure 2). On hospital day 7, he was started on
ledipasvir/sofosbuvir 90–400 mg daily as well as prednisone
40 mg daily for HCV-induced cryoglobulinemic vasculitis
involving the small vessels of the skin and the large vessel of
the aorta. The patient completed a 12-week course of

Figure 2. (A) Blanching, erythematous macules, and papules on the
patient’s upper back. (B) Histopathology showing papillary dermal edema
and a superﬁcial perivascular inﬂammatory inﬁltrate.
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ledipasvir/sofosbuvir and subsequently achieved a sustained
virologic response. Repeat magnetic resonance angiography
4 months later showed complete resolution of the thickening
in the abdominal aorta and common iliac arteries (Figure 3).
Repeat cryoglobulin level was negative 2 months after starting ledipasvir/sofosbuvir, and the patient was able to be
tapered off steroids within 7 months.

DISCUSSION
The prevalence of cryoglobulinemia in HCV varies from 10–
54% of infected individuals and is more common in women,
older patients, and those with longer durations of infection.4-7
Clinical symptoms include palpable purpura, arthralgias,
Raynaud’s phenomenon, peripheral neuropathy, and renal
impairment.8 HCV-associated cryoglobulinemic vasculitis typically affects small and medium-sized vessels, while involvement of larger vessels, such as the aorta, is rarely reported.
Rather, aortitis is classically caused by bacterial infections
such as Salmonella, Staphylococcus, or syphilis, or it is secondary to inﬂammatory conditions including giant cell arteritis, Takayasu arteritis, rheumatoid arthritis, and systemic
lupus erythematosus.9,10 While the reasons for these differences in vessel size are not completely known, a possible explanation is that cryoglobulinemic vasculitis is frequently
mediated by immune complex formation, which is more likely
to precipitate in smaller vessels.11 Conversely, giant cell arteritis and Takayasu arteritis involve large-vessel inﬁltration of Tcells, macrophages, and monocytes.12
Although infrequently seen, a few case series and case reports
have established an association between cryoglobulinemia
acgcasereports.gi.org
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and aortic abnormalities in non–HCV-infected patients.13,14
However, aortitis secondary to HCV-associated cryoglobulinemia is not well deﬁned. Fukunaga et al. described a case of an elderly man with known HCV-related cryoglobulinemia who
presented with an aortic dissection and histopathology that
showed deposition of IgG within the aortic wall.15 The man was
treated with steroids, underwent emergent reconstructive surgery, and ultimately survived. However, the authors did not
comment on deﬁnitive treatment of his underlying HCV. Our
case is unique because our patient’s aortitis resolved with oral
antiviral therapy in addition to corticosteroids.
As previously mentioned, HCV-related cryoglobulinemic vasculitis is most commonly associated with type II and III cryoglobulins, whereas type I cryoglobulinemia is typically seen in
lymphoproliferative disorders.16,17 However, type I cryoglobulins have also occasionally been reported in patients with HCV.
A case series by Trejo et al. reported that, out of 90 patients
with type-able cryoglobulinemia, 33 patients had type I cryoglobulins, 83% of which also had concurrent HCV infection.3 Our
case highlights a unique presentation of HCV-related cryoglobulinemic vasculitis associated with type I cryoglobulins.
Lymphoproliferative disorders were ruled out via negative serum electrophoreses and the absence of lymphadenopathy on
computed tomography imaging. HCV as the etiology of this
patient’s type I cryoglobulinemia was also supported by the resolution of vascular inﬂammation and clearance of serum cryoglobulins with antiviral therapy.
In accordance with guidelines, patients with HCV-associated
cryoglobulinemic vasculitis should receive treatment for HCV,
with direct-acting antivirals being the preferred agents.18,19
While these guidelines were based on studies of vasculitis in
small and medium-sized vessels, the present case suggests that
these recommendations should be extrapolated to include
large-vessel vasculitis. Corticosteroids are often used as an
additive therapy to help mitigate vasculitic ﬂares.20 Our patient
was treated with steroids and antiviral therapy, achieving both
sustained virologic response and resolution of vasculitis.
This case highlights a rare presentation of HCV-associated aortitis caused by type I cryoglobulins that ultimately resolved
with antiviral therapy. The rapid improvement of vasculitis,
cryoglobulinemia, and HCV infection following initiation of
sofosbuvir/ledipasvir emphasizes the need to search for a viral etiology in similar cases and to promptly begin potentially
life-saving therapy.
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